CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy Study of Oncolytic Virus（Intratumoral Injection）in Combination With HX-008（Intravenous Injection）and Axitinib in Melanoma Patients With Liver Metastasis Who Lack or Become Refractory to Standard Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05070221
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:28.423964+00:00
Published At: 2021-10-07T00:00:00+00:00
Record Updated At: 2021-10-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Melanoma Stage IV"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-10-07"
protocolSection.identificationModule.nctId: "NCT05070221"
protocolSection.identificationModule.officialTitle: "Safety and Efficacy Study of Oncolytic Virus\uff08Intratumoral Injection\uff09in Combination With HX-008\uff08Intravenous Injection\uff09and Axitinib in Melanoma Patients With Liver Metastasis Who Lack or Become Refractory to Standard Treatment"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.